Articles From: Sears Holdings Names Alasdair James As Kmart's President And Chief Member Officer to SeaWorld Shareholder Alert -- National Securities Law Firm Announces Class Action Lawsuit on Behalf of Shareholders of SeaWorld Entertainment, Inc. - SEAS


Role critical to meeting needs of the Kmart Shop Your Way member HOFFMAN ESTATES, Ill.
Sign-up for Sears Holdings Names Alasdair James As Kmart's President And Chief Member Officer investment picks
OAK BROOK, Ill.
Sign-up for Sears Holdings Names Hub Group As A Top Supplier investment picks
HOFFMAN ESTATES, Ill , Aug.
Sign-up for Sears Holdings Reports Second Quarter 2014 Results investment picks
HOFFMAN ESTATES, Ill.
Sign-up for Sears Holdings To Announce Financial Results investment picks
HOFFMAN ESTATES, Ill.
Sign-up for Sears Hometown and Outlet Stores, Inc. Reports Second Quarter 2014 Results investment picks
Sears Holdings (SHLD) said, in response to a "misleading article recently published," that it has had "no material interruptions in the flow of goods to our company." The department store chain said it has "significant financial flexibility" to execute its transformation to meet its obligations, including paying its vendors and suppliers.
Sign-up for Sears responds to 'misleading article' about vendor troubles investment picks
Shares of Sears Holding (SHLD) tumbled as much as 14%, before paring some losses, following a report that at least one vendor was halting shipments to the department store chain because insurance firms for the suppliers are seeking to reduce coverage.
Sign-up for Sears shares tumble after report of vendor halting shipments investment picks
Sears Holdings Corp.
Sign-up for Sears should liquidate while it can: Credit Suisse investment picks
Retailer Sears Holding Corp.
Sign-up for Sears to raise $380 million from sale of Sears Canada shares investment picks
2014/7/24
New shopping conveniences, on-trend style and products, Shop Your Way® benefits makeSears the go-to back-to-school partner HOFFMAN ESTATES, Ill.
Sign-up for Sears® Helps Mom, Family Get "Back to School, Back to You" investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0959490001&sourceType=1 http://www.ccnmatthews.com/logos/20080327-SEALOGO.JPG HONG KONG, CHINA --
Sign-up for Seaspan Reports Financial Results for the Three and Six Months Ended June 30, 2014 investment picks
2014/8/16
Seattle area kids and their families, many from the Boys & Girls Club of King County, tested their IRONMAN skills today at the UnitedHealthcare IRONKIDS Seattle Fun Run at Genesee Park in south Seattle.
Sign-up for Seattle Area Kids Test Their “IRONMAN” Skills at UnitedHealthcare IRONKIDS Fun Run investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Genmab A/S (OMX: GEN) today announced that the companies have entered into an additional antibody-drug conjugate (ADC) collaboration.
Sign-up for Seattle Genetics and Genmab Enter Into New Antibody-Drug Conjugate Collaboration investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that patients with Hodgkin lymphoma (HL) who received ADCETRIS (brentuximab vedotin) as consolidation therapy immediately following an autologous stem cell transplantation (ASCT) lived significantly longer without disease progression compared to patients who received placebo.
Sign-up for Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for Consolidation in Post-Transplant Hodgkin Lymphoma investment picks
Seattle Genetics, Inc. (Nasdaq:SGEN) today highlighted ADCETRIS (brentuximab vedotin) data to be presented at the 2014 European Society for Medical Oncology (ESMO) Congress being held September 26-30, 2014 in Madrid, Spain.
Sign-up for Seattle Genetics Highlights Updated Progression-Free Survival and Overall Survival Data from ADCETRIS® (Brentuximab Vedotin) Frontline PTCL Phase 1 Clinical Trial at the ESMO 2014 Congress investment picks
Seattle Genetics, Inc. (NASDAQ:SGEN) today announced the initiation of a phase 1 clinical trial evaluating SGN-CD70A for CD70-positive relapsed or refractory non-Hodgkin lymphoma (NHL) and metastatic renal cell carcinoma (RCC). SGN-CD70A is a novel antibody-drug conjugate (ADC) targeted to CD70 utilizing the company’s newest ADC technology.
Sign-up for Seattle Genetics Initiates Phase 1 Clinical Trial of Antibody-Drug Conjugate SGN-CD70A for Non-Hodgkin Lymphoma and Renal Cell Carcinoma investment picks
Seattle Genetics, Inc. (Nasdaq: SGEN) today reported financial results for the second quarter and six months ended June 30, 2014.
Sign-up for Seattle Genetics Reports Second Quarter 2014 Financial Results investment picks
Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that its management will host a conference call and webcast on Monday, September 29, 2014, at 5:30 a.m. Pacific Time (PT) / 8:30 a.m. Eastern Time (ET) regarding top-line results from its ADCETRIS phase 3 AETHERA clinical trial for Hodgkin lymphoma patients at risk of relapse following autologous stem cell transplant.
Sign-up for Seattle Genetics to Host Conference Call and Webcast on September 29, 2014 Regarding Top-line Data from ADCETRIS® (brentuximab vedotin) Phase 3 AETHERA Clinical Trial investment picks
Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2014, at 1:30 p.m. Eastern Time.
Sign-up for Seattle Genetics to Present at Morgan Stanley Healthcare Conference investment picks
2014/7/19
By Sheila V.
Sign-up for SeaWorld battles whale of a protest investment picks
ORLANDO, Fla.
Sign-up for SeaWorld Entertainment, Inc. Announces Quarterly Dividend investment picks
2014/9/25
ORLANDO, Fla.
Sign-up for SeaWorld Kids Makes A Splash With Launch Of Mobile Games Collection investment picks
2014/9/8
Veterans and as many as five guests Receive 50 Percent off Single-Day Admission to SeaWorld, Busch Gardens Parks and Sesame Place ORLANDO, Fla.
Sign-up for SeaWorld Parks & Entertainment Salutes Veterans with "Waves of Honor" Special Online Offer investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Sears Holdings Names Alasdair James As Kmart's President And Chief Member Officer to SeaWorld Shareholder Alert -- National Securities Law Firm Announces Class Action Lawsuit on Behalf of Shareholders of SeaWorld Entertainment, Inc. - SEAS
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices